Tesla
TSLA
Broadcom
AVGO
Netflix
NFLX
Amazon
AMZN
Cisco
CSCO
US Stock MarketDetailed Quotes
PCSA Processa Pharmaceuticals
- 0.8710
- +0.0338+4.04%
Close Dec 24 13:00 ET
- 0.8403
- -0.0307-3.52%
Post 15:07 ET
2.85MMarket Cap-0.18P/E (TTM)
0.8820High0.8182Low39.57KVolume0.8182Open0.8372Pre Close33.57KTurnover1.37%Turnover RatioLossP/E (Static)3.27MShares7.400052wk High0.76P/B2.52MFloat Cap0.812052wk Low--Dividend TTM2.90MShs Float284.7980Historical High--Div YieldTTM7.62%Amplitude0.8120Historical Low0.8480Avg Price1Lot Size
Processa Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -104.58%-3.6M | -62.07%-3.35M | 3.08%-2.05M | 16.05%-8.06M | 14.96%-2.12M | 40.80%-1.76M | 11.42%-2.06M | -17.26%-2.11M | -10.18%-9.61M | 8.42%-2.5M |
| Net income from continuing operations | -62.57%-3.38M | -15.22%-3.01M | 32.21%-2.73M | 59.45%-11.12M | 81.52%-2.4M | 65.42%-2.08M | 49.41%-2.61M | -24.63%-4.02M | -139.98%-27.42M | -308.70%-13.01M |
| Depreciation and amortization | 147.56%203 | --139 | --139 | -99.97%222 | -99.93%140 | -99.96%82 | --0 | --0 | -0.31%788.5K | 0.00%197.12K |
| Other non cash items | 7.10%22.03K | 5.53%21.3K | -98.39%21.37K | 256.91%1.39M | -63.13%20.98K | -64.74%20.57K | -91.90%20.18K | 5,083.37%1.33M | 1.50%390.13K | 161.54%56.89K |
| Change In working capital | -350.42%-394.33K | -344.06%-509.57K | 107.08%488.34K | 11.33%605.21K | -98.55%3.13K | 137.21%157.47K | -44.78%208.79K | -36.69%235.82K | 146.12%543.6K | 130.86%216.15K |
| -Change in receivables | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 941.10%70.27K | --0 |
| -Change in prepaid assets | -122.97%-39.82K | -507.67%-1.05M | -83.07%68.67K | 354.45%956.83K | 236.11%120.49K | 541.50%173.36K | 365.13%257.37K | 87.16%405.62K | 120.68%210.55K | 74.97%-88.53K |
| -Change in payables and accrued expense | -16,690.35%-333.96K | 1,936.28%537.5K | 407.06%463.1K | -177.38%-272.72K | -128.05%-90.64K | 99.54%-1.99K | -108.44%-29.27K | -236.50%-150.81K | 311.25%352.44K | 199.28%323.14K |
| -Change in other current liabilities | -4.33%-20.55K | -4.34%-20.15K | -11.40%-21.08K | 10.28%-78.9K | -13.23%-20.97K | 11.14%-19.7K | 19.76%-19.31K | 18.40%-18.93K | -0.85%-87.94K | 19.77%-18.52K |
| -Change in other working capital | --0 | --22.3K | -43,692.16%-22.33K | 99.30%-12 | -11,378.43%-5.75K | --5.79K | --0 | 97.12%-51 | -101.99%-1.72K | -97.12%51 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -104.58%-3.6M | -62.07%-3.35M | 3.08%-2.05M | 16.05%-8.06M | 14.96%-2.12M | 40.80%-1.76M | 11.42%-2.06M | -17.26%-2.11M | -10.18%-9.61M | 8.42%-2.5M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -2.78K | 0 | 0 | 0 | ||||||
| Net PPE purchase and sale | ---- | ---- | ---- | ---2.78K | --0 | ---- | ---- | ---- | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | ---2.78K | --0 | ---- | ---- | ---- | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,855.95%926.2K | -3.41K | -1.40%6.26M | 1,712.15%6.27M | 42.89%-30.61K | -49.65%-52.75K | 0 | 2,217.36%6.35M | -103.97%-388.84K | -140.80%-53.6K |
| Net issuance payments of debt | ---1.44K | ---1.41K | ---895 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net common stock issuance | --927.63K | ---2.01K | -1.25%6.27M | 1,725.71%6.32M | 42.89%-30.61K | --0 | --0 | 2,217.36%6.35M | -103.89%-388.84K | -138.96%-53.6K |
| Net other financing activities | ---- | --0 | ---8.56K | ---52.75K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,855.95%926.2K | ---3.41K | -1.40%6.26M | 1,712.15%6.27M | 42.89%-30.61K | -49.65%-52.75K | --0 | 2,217.36%6.35M | -103.97%-388.84K | -140.80%-53.6K |
| Net cash flow | ||||||||||
| Beginning cash position | -35.80%5.57M | -16.96%8.92M | -27.64%4.71M | -60.58%6.5M | -24.23%6.86M | -28.08%8.68M | -25.38%10.74M | -60.58%6.5M | 7.01%16.5M | -52.58%9.05M |
| Current changes in cash | -47.52%-2.68M | -62.23%-3.35M | -0.56%4.21M | 82.02%-1.8M | 15.54%-2.15M | 39.64%-1.82M | 11.42%-2.06M | 301.53%4.24M | -1,024.21%-9.99M | 1.72%-2.55M |
| End cash Position | -57.85%2.89M | -35.80%5.57M | -16.96%8.92M | -27.64%4.71M | -27.64%4.71M | -24.23%6.86M | -28.08%8.68M | -25.38%10.74M | -60.58%6.5M | -60.58%6.5M |
| Free cash flow | -104.45%-3.61M | -62.07%-3.35M | 3.08%-2.05M | 16.02%-8.07M | 14.96%-2.12M | 40.70%-1.76M | 11.42%-2.06M | -17.26%-2.11M | -10.18%-9.61M | 8.42%-2.5M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.